LifeVantage Co. (NASDAQ:LFVN) Shares Purchased by Hillsdale Investment Management Inc.

Hillsdale Investment Management Inc. lifted its stake in LifeVantage Co. (NASDAQ:LFVN) by 7.3% in the fourth quarter, HoldingsChannel reports. The fund owned 14,720 shares of the company’s stock after purchasing an additional 1,000 shares during the quarter. Hillsdale Investment Management Inc.’s holdings in LifeVantage were worth $258,000 at the end of the most recent reporting period.

Other institutional investors and hedge funds have also made changes to their positions in the company. American Century Companies Inc. raised its holdings in LifeVantage by 50.5% during the fourth quarter. American Century Companies Inc. now owns 95,552 shares of the company’s stock worth $1,675,000 after purchasing an additional 32,055 shares in the last quarter. Bank of New York Mellon Corp increased its position in shares of LifeVantage by 43.9% during the 4th quarter. Bank of New York Mellon Corp now owns 74,183 shares of the company’s stock valued at $1,300,000 after purchasing an additional 22,620 shares during the period. Copeland Capital Management LLC bought a new stake in shares of LifeVantage in the 4th quarter worth $65,000. Ritholtz Wealth Management lifted its holdings in shares of LifeVantage by 65.2% in the fourth quarter. Ritholtz Wealth Management now owns 47,348 shares of the company’s stock valued at $830,000 after buying an additional 18,682 shares during the period. Finally, Barclays PLC boosted its stake in LifeVantage by 38.2% during the third quarter. Barclays PLC now owns 41,966 shares of the company’s stock valued at $507,000 after buying an additional 11,608 shares in the last quarter. 35.32% of the stock is currently owned by institutional investors.

Insiders Place Their Bets

In other news, Director Raymond B. Greer sold 8,000 shares of the firm’s stock in a transaction on Monday, February 10th. The stock was sold at an average price of $20.15, for a total value of $161,200.00. Following the completion of the sale, the director now owns 99,288 shares of the company’s stock, valued at $2,000,653.20. This trade represents a 7.46 % decrease in their ownership of the stock. The sale was disclosed in a filing with the SEC, which is available at this link. Corporate insiders own 20.65% of the company’s stock.

Analysts Set New Price Targets

Several brokerages have commented on LFVN. Craig Hallum started coverage on shares of LifeVantage in a research report on Tuesday, January 14th. They issued a “buy” rating and a $35.00 price target on the stock. Lake Street Capital started coverage on shares of LifeVantage in a research note on Thursday, December 19th. They set a “buy” rating and a $26.00 target price for the company.

LifeVantage Stock Up 0.6 %

Shares of NASDAQ LFVN opened at $15.56 on Tuesday. LifeVantage Co. has a 52-week low of $5.22 and a 52-week high of $27.38. The stock has a market capitalization of $195.29 million, a price-to-earnings ratio of 27.79 and a beta of 0.74. The stock’s fifty day simple moving average is $19.36 and its 200 day simple moving average is $15.84.

LifeVantage (NASDAQ:LFVN) last posted its quarterly earnings data on Wednesday, February 5th. The company reported $0.22 earnings per share (EPS) for the quarter, topping the consensus estimate of $0.14 by $0.08. LifeVantage had a return on equity of 34.29% and a net margin of 3.46%.

LifeVantage Announces Dividend

The company also recently disclosed a quarterly dividend, which was paid on Monday, March 17th. Investors of record on Monday, March 3rd were paid a $0.04 dividend. This represents a $0.16 dividend on an annualized basis and a yield of 1.03%. The ex-dividend date of this dividend was Monday, March 3rd. LifeVantage’s dividend payout ratio is 28.57%.

LifeVantage Profile

LifeVantage Corporation engages in the identification, research, development, formulation, and sale of advanced nutrigenomic activators, dietary supplements, nootropics, pre- and pro-biotics, weight management, skin and hair care, bath and body, and targeted relief products. It offers Protandim, a dietary supplement; LifeVantage Omega+, a dietary supplement that combines DHA and EPA Omega-3 fatty acids, Omega-7 fatty acids, and vitamin D3; LifeVantage ProBio, a dietary supplement to support gut health; PhysIQ, a weight management system; LifeVantage IC Bright, a supplement to support eye and brain health, reduce eye fatigue and strain, supports cognitive functions, and support normal sleep patterns; Petandim for Dogs, a supplement to combat oxidative stress in dogs; and Axio, a nootropic energy drink mix.